Pliant Therapeutics, Inc. Common Stock (PLRX) is a publicly traded Healthcare sector company. As of May 21, 2026, PLRX trades at $1.19 with a market cap of $73.07M and a P/E ratio of -0.50. PLRX moved +5.22% today. Year to date, PLRX is -6.61%; over the trailing twelve months it is -12.41%. Its 52-week range spans $1.09 to $16.10. Analyst consensus is neutral with an average price target of $2.67. Rallies surfaces PLRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes PLRX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $1.19 |
| Market Cap | $73.07M |
| P/E Ratio | -0.50 |
| EPS | $-2.43 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.10 |
| 52-Week Low | $1.09 |
| Volume | 906 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-149.34M |
| Gross Margin | 0.00% |
5 analysts cover PLRX: 0 strong buy, 1 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $2.67.